|
End-of-day quote
Shanghai S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 36.13 CNY | +1.77% |
|
-1.37% | -15.09% |
| Market Cap | 11.5B 1.72B 1.54B 1.42B 1.29B 2.41B 164B 2.45B 17.12B 6.78B 85.76B 6.47B 6.33B 270B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.89B 1.33B 1.19B 1.1B 997M 1.86B 127B 1.9B 13.23B 5.24B 66.3B 5B 4.9B 209B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | +1.77% | ||
| 1 week | -1.37% | ||
| Current month | -0.61% | ||
| 1 month | -0.80% | ||
| 3 months | -6.45% | ||
| 6 months | -12.65% | ||
| Current year | -15.09% |
| 1 week | 34.85 |  | 36.7 |
| 1 month | 34.85 | | 37.47 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 48.99 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 2014-11-19 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 2019-10-24 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 2015-01-07 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 2015-01-07 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 2015-01-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | -1.37% | -23.03% | +4.65% | 1.69B | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,165B | |
| -1.42% | +3.23% | +37.07% | +74.26% | 645B | |
| +0.16% | +0.08% | +25.14% | +97.36% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | -0.47% | +66.63% | +40.56% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | |
| -0.73% | -0.10% | +29.24% | +101.19% | 195B | |
| Average | -0.73% | +2.19% | +30.38% | +63.72% | 405.72B | |
| Weighted average by Cap. | -1.17% | +3.17% | +40.57% | +81.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 421M 376M 347M 315M 589M 39.94B 598M 4.18B 1.65B 20.93B 1.58B 1.55B 65.98B | 2.98B 447M 399M 369M 334M 625M 42.43B 636M 4.44B 1.76B 22.23B 1.68B 1.64B 70.09B |
| Net income | 1.05B 158M 141M 130M 118M 220M 14.96B 224M 1.56B 619M 7.84B 591M 579M 24.71B | 938M 141M 126M 116M 105M 197M 13.35B 200M 1.4B 553M 6.99B 528M 516M 22.05B |
| Net Debt | -2.35B -353M -315M -291M -264M -493M -33.47B -501M -3.5B -1.39B -17.53B -1.32B -1.29B -55.28B | -2.61B -391M -349M -323M -292M -547M -37.13B -556M -3.88B -1.54B -19.45B -1.47B -1.44B -61.33B |
Employees
671
Sector
Pharmaceuticals
Calendar
Oct. 30
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | CN¥36.13 | +1.77% | 2,868,206 |
| 26-10-22 | CN¥35.50 | -2.63% | 2,580,670 |
| 26-10-21 | CN¥36.46 | +0.16% | 1,638,980 |
| 26-10-20 | CN¥36.40 | -0.22% | 2,158,782 |
| 26-10-19 | CN¥36.48 | +1.28% | 2,345,650 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
